Literature DB >> 8172997

Associations between bladder cancer risk factors and tumor stage and grade at diagnosis.

S R Sturgeon1, P Hartge, D T Silverman, A F Kantor, W M Linehan, C Lynch, R N Hoover.   

Abstract

Using data on 1,860 bladder cancer cases and 3,934 population-based controls from the National Bladder Cancer Study, we examined associations between suspected bladder cancer risk factors and tumor stage and grade. Employment in a high-risk occupation was associated with the entire clinical spectrum of bladder cancer rather than a particular tumor stage or grade. For example, relative risks (RR) were similar for noninvasive and invasive disease (1.5 and 1.6, respectively). Cigarette smoking also increased risk of the entire clinical spectrum of bladder cancer, but the more advanced the stage, the stronger the effect. For example, relative risks of noninvasive and invasive bladder cancer for current heavy smokers were 3.0 and 5.2, respectively. Cigarette smoking was associated with higher risk of low-grade than high-grade tumors, once stage of disease was taken into account. Compared with whites, nonwhites were at a lower risk of noninvasive bladder cancer (RR = 0.4) but at similar risk of invasive bladder cancer (RR = 1.1), a pattern indicating racial differences in health practices related to bladder cancer detection. History of urinary tract infections and bladder stones was associated with increasing relative risks for advanced tumor stage. Heavy artificial sweetener use was associated with higher-grade, poorly differentiated tumors. Coffee consumption and family history of bladder cancer were not consistently associated with tumor stage or grade. Overall, different clinical presentations of bladder cancer share most suspected bladder cancer risk factors, including employment in a high-risk occupation and cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172997     DOI: 10.1097/00001648-199403000-00012

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  23 in total

1.  Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

Authors:  Alan R Schned; Petra Lenz; Lee E Moore; Alison Johnson; Michael Jones; Masatoshi Kida; Debra T Silverman; Molly Schwenn; Karl T Kelsey; Angeline S Andrew; Dalsu Baris; Margaret R Karagas
Journal:  ISRN Pathol       Date:  2012

2.  Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens.

Authors:  K Teschke; M S Morgan; H Checkoway; G Franklin; J J Spinelli; G van Belle; N S Weiss
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

3.  Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.

Authors:  Matthew E Nielsen; Angela B Smith; Anne-Marie Meyer; Tzy-Mey Kuo; Seth Tyree; William Y Kim; Matthew I Milowsky; Raj S Pruthi; Robert C Millikan
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

4.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Authors:  Montserrat Garcia-Closas; Yuanqing Ye; Nathaniel Rothman; Jonine D Figueroa; Núria Malats; Colin P Dinney; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Zhaoming Wang; Jie Lin; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jian Gu; Xia Pu; Amy Hutchinson; Yi-Ping Fu; Laurie Burdett; Meredith Yeager; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock; Xifeng Wu
Journal:  Hum Mol Genet       Date:  2011-08-08       Impact factor: 6.150

5.  New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies.

Authors:  Veronica Sciannameo; Angela Carta; Angelo d'Errico; Maria Teresa Giraudo; Francesca Fasanelli; Cecilia Arici; Milena Maule; Paolo Carnà; Paolo Destefanis; Luigi Rolle; Paolo Gontero; Giovanni Casetta; Andrea Zitella; Giuseppina Cucchiarale; Paolo Vineis; Stefano Porru; Carlotta Sacerdote; Fulvio Ricceri
Journal:  Int Arch Occup Environ Health       Date:  2018-11-30       Impact factor: 3.015

6.  Cytotoxic effects of aspartame on human cervical carcinoma cells.

Authors:  Muthuraman Pandurangan; Gansukh Enkhtaivan; Doo Hwan Kim
Journal:  Toxicol Res (Camb)       Date:  2015-09-29       Impact factor: 3.524

7.  Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.

Authors:  Chandra Sekhar Amara; Chandrashekar R Ambati; Venkatrao Vantaku; Danthasinghe Waduge Badrajee Piyarathna; Sri Ramya Donepudi; Shiva Shankar Ravi; James M Arnold; Vasanta Putluri; Gurkamal Chatta; Khurshid A Guru; Hoda Badr; Martha K Terris; Roni J Bollag; Arun Sreekumar; Andrea B Apolo; Nagireddy Putluri
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

8.  Genetic susceptibility to distinct bladder cancer subphenotypes.

Authors:  Lin T Guey; Montserrat García-Closas; Cristiane Murta-Nascimento; Josep Lloreta; Laia Palencia; Manolis Kogevinas; Nathaniel Rothman; Gemma Vellalta; M Luz Calle; Gaëlle Marenne; Adonina Tardón; Alfredo Carrato; Reina García-Closas; Consol Serra; Debra T Silverman; Stephen Chanock; Francisco X Real; Núria Malats
Journal:  Eur Urol       Date:  2009-08-12       Impact factor: 20.096

9.  Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Michael Rink; Evanguelos Xylinas; Vitaly Margulis; Eugene K Cha; Behfar Ehdaie; Jay D Raman; Felix K Chun; Kazumasa Matsumoto; Yair Lotan; Helena Furberg; Marek Babjuk; Armin Pycha; Christopher G Wood; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

Review 10.  Lifestyle issues and genitourinary tumours.

Authors:  Frank Sommer; Theo Klotz; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2003-12-12       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.